FMS (Fresenius Medical Care AG) Institutional Ownership: 7.89% (As of Jul. 02, 2026)


FMS Fresenius Medical Care AG FMS
72 GF Score
Price $22.86
GF Value $23.57
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG Institutional Ownership?

Fresenius Medical Care AG FMS +1.11% 72 Institutional Ownership is 7.89% as of Jul. 02, 2026. GuruFocus rates FMS with a GF Score™ of 72/100 and a GF Value™ of $23.57 (Fairly Valued). The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Fresenius Medical Care AG's institutional ownership is 7.89%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Fresenius Medical Care AG's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Fresenius Medical Care AG's Float Percentage Of Total Shares Outstanding is 0.00%.

Fresenius Medical Care AG Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG Institutional Ownership Chart

Fresenius Medical Care AG Historical Data

The historical data trend for Fresenius Medical Care AG can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 6.18 6.19 6.17 6.36 6.36 6.37 6.57 6.61 6.61 6.61
FMS
72GF Score
Fresenius Medical Care AG FMS
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius Medical Care AG Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 7.89% mean?
Fresenius Medical Care AG (FMS) has a Institutional Ownership of 7.89% as of Jul. 02, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Fresenius Medical Care AG and its competitors.
Is Fresenius Medical Care AG's Institutional Ownership too high?
Fresenius Medical Care AG's current Institutional Ownership is 7.89%. Overall, Fresenius Medical Care AG has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Institutional Ownership compare to HCA and THC?
Fresenius Medical Care AG's Institutional Ownership of 7.89% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Healthcare Providers & Services company?
A good Institutional Ownership depends on the Healthcare Providers & Services industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Fresenius Medical Care AG and its competitors. Fresenius Medical Care AG's current Institutional Ownership is 7.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (FMS) is currently considered Fairly Valued. The stock's GF Value™ is $23.57, compared to a current price of $22.86 — trading 3% below its estimated fair value. The current Institutional Ownership is 7.89%. Fresenius Medical Care AG's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Fresenius Medical Care AG (FMS), the current Institutional Ownership is 7.89% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (FMS) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued. The current stock price of $22.86 is trading 3% below its estimated GF Value™ of $23.57. GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.

Key valuation signals for FMS:

  • Institutional Ownership: 7.89%
  • GF Value™: $23.57 vs. price of $22.86 (3% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the FMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
72GF Score

Get the complete analysis for FMS

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.86
Price
$23.57
GF Value